Combination Vaccine Equipment
-
Manufactured by Bilthoven Biologicalsbased in NETHERLANDS
The DT-IPV combination vaccine (diphteria, tetanus and poliomyelitis) can be used as the first (primary) inoculation, or as a booster vaccination. The Dutch Vaccination Program (RVP), delivers booster vaccination via Bilthoven Biologicals to each 9 year old. DT-IPV vaccine is available in ...
-
Manufactured by KM Biologics Co. Ltd.based in JAPAN
In additions to protective antigens against Bordetella pertussis, diphtheria toxoid and tetanus toxoid, Quattrovac also contains inactivated poliovirus types 1, 2 and 3 derived from Sabin strains. Quattrovac does not contain thimerosal or other preservatives, and is provided in an easy to use ...
-
Manufactured by Novavaxbased in USA
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an early stage, we believe that a combination vaccine against both ...
-
Manufactured by Novavaxbased in USA
Our recombinant nanoparticle vaccine technology combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic particles that target a variety of viral pathogens. Our recombinant vaccine engineering takes a new approach to provide robust and functional immunity, which may be more efficacious ...
-
based in USA
Synthetic Genomics has engineered a proprietary RNA replicon platform to selectively stimulate the immune system and deliver targeted therapies produced within a person’s own body. Our RNA platform overcomes common shortcomings of traditional replicon and messenger RNA (mRNA) technologies, enabling a new class of vaccines and ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug ...
-
based in USA
Influenza severely affects over 3 million people annually and results in up to 650,000 deaths annually from the associated respiratory diseases caused by seasonal influenza. Due to frequent mutations of the influenza virus, current strain-specific influenza vaccines are not designed to offer protection against mutated flu ...
-
Manufactured by Icosavax, Inc.based in USA
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in ...
-
Manufactured by ORYX GmbH & Co. KGbased in GERMANY
of HR-HPV-mediated cell transformation. About 5% of all cancers are associated with HR-HPV including virtually all cervical cancers, 85-95% of anal and vulvar cancers, 20-40% of vaginal and penile cancers and 30-60% of head and neck cancers. Currently, two prophylactic vaccines are on the market that induce HPV-type specific protective immunity but ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you